Δημοφιλείς αναρτήσεις

! # Ola via Alexandros G.Sfakianakis on Inoreader

Τρίτη, 9 Απριλίου 2019

MedWorm Cancer & Oncology Clinical Trials


Phase 1/2 Trial of TC-210 T Cells in Patients With Advanced Mesothelin-Expressing Cancer
Conditions:   Mesothelioma;   Mesothelioma, Malignant;   Mesothelioma; Pleura;   Mesotheliomas Pleural;   Mesothelioma Peritoneum;   Cholangiocarcinoma;   Cholangiocarcinoma Recurrent;   Ovarian Cancer;   Non Small Cell Lung Cancer;   Non Small Cell Lung Cancer Metastatic Interventions:   Drug: TC-210 T Cells;   Drug: fludarabine;   Drug: cyclophosphamide;   Biological: anti-PD1 Sponsor:   TCR2 Therapeutics Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma
Conditions:   Stage II, III;   Nasopharyngeal Squamous Cell Carcinoma;   Induction Chemotheray;   Concurrent Chemoradiotherapy;   Reduce Treatment Intensity Interventions:   Drug: Docetaxel;   Drug: Cisplatin;   Radiation: IMRT Sponsor:   Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
A Study of Onapristone ER in Gynecologic Cancers That Respond to Progesterone
Conditions:   Granulosa Cell Ovarian Cancer;   Low Grade Serous Ovarian/ Primary Peritoneal Cancer;   Endometrioid Endometrial Cancer Intervention:   Drug: Onapristone ER Sponsors:   Memorial Sloan Kettering Cancer Center;   Context Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer
Conditions:   Esophageal Cancer;   Non Small Cell Lung Cancer Intervention:   Biological: Personalized mRNA Tumor Vaccine Sponsors:   Stemirna Therapeutics;   The First Affiliated Hospital of Zhengzhou University Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer
Conditions:   Endometrial Cancer;   Overweight Intervention:   Behavioral: Profile by Sanford weight management plan Sponsor:   Sanford Health Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma
Conditions:   Hepatocellular Carcinoma;   Cirrhosis;   Liver Failure Interventions:   Drug: Branch Chain Amino Acid;   Other: maltodextrin Sponsors:   Louisiana State University Health Sciences Center in New Orleans;   University Medical Center-New Orleans Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Pain Phenotyping of Patients With Bone Cancer Pain
Conditions:   Pain;   Bone Metastases;   Metastatic Breast Cancer Intervention:   Sponsors:   University of Copenhagen;   The Novo Nordic Foundation Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer
Conditions:   Breast Cancer;   Triple Negative Breast Cancer;   HER2-positive Breast Cancer Interventions:   Drug: Nab-paclitaxel;   Drug: Carboplatin;   Drug: Herceptin Sponsor:   Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Condition:   Hepatocellular Carcinoma Intervention:   Biological: TBI 302 Sponsor:   Therapure Biopharma Inc Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Alpha-Lipoic Acid in Breast Cancer Patients
Conditions:   Chemotherapeutic Toxicity;   Breast Cancer Interventions:   Dietary Supplement: Alpha-lipoic acid;   Drug: Chemotherapy Sponsor:   Damanhour University Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Detection of the Emergence of RAS Mutations in Circulating DNA in Patients With mCRC During Treatment With Anti-EGFR Therapy
Condition:   Metastatic Colorectal Cancer Intervention:   Genetic: Blood sample Sponsor:   Institut du Cancer de Montpellier - Val d'Aurelle Recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
Conditions:   Metastatic Pancreatic Cancer;   Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma Resectable;   Pancreatic Ductal Adenocarcinoma;   Pancreatic Metastasis Interventions:   Drug: Ascorbic Acid;   Drug: Paclitaxel protein-bound;   Drug: Cisplatin;   Drug: Gemcitabine Sponsors:   Medical College of Wisconsin;   Cancer Research UK;   Stand Up To Cancer;   Lustgarten Foundation;   Destroy Pancreatic Cancer;   Translational Genomics Research Institute;   HonorHealth Research Institute...
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2
Condition:   HER2 Positive Breast Carcinoma Intervention:   Sponsor:   Anhui Provincial Hospital Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers
Condition:   Advanced Malignancies Interventions:   Drug: AZD7648;   Drug: Pegylated liposomal doxorubicin (PLD);   Drug: Olaparib Sponsors:   AstraZeneca;   Parexel Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Ultrasound Spectroscopy as Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
Conditions:   Prostate Cancer;   Head and Neck Cancer;   Rectal Cancer Intervention:   Other: Imaging Sponsor:   Sunnybrook Health Sciences Centre Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Programmed Death-1 (PD-1) Antibody Combined With IMRT in Recurrent Nasopharyngeal Carcinoma Patients
Condition:   Recurrent Nasopharyngeal Carcinoma Interventions:   Drug: PD-1 blocking antibody;   Radiation: IMRT Sponsor:   Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
Conditions:   Von-Hippel Lindau;   Kidney Disease, Chronic Interventions:   Drug: Perflutren lipid microsphere;   Drug: Sulfur hexafluoride lipid microspheres Sponsors:   UNC Lineberger Comprehensive Cancer Center;   Lantheus Medical Imaging;   Vanderbilt University Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions:   Platinum-Resistant Fallopian Tube Carcinoma;   Platinum-Resistant Ovarian Carcinoma;   Platinum-Resistant Primary Peritoneal Carcinoma;   Progressive Disease;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Refractory Fallopian Tube Carcinoma;   Refractory Ovarian Carcinoma;   Refractory Primary Peritoneal Carcinoma;   Stage III Fallopian Tube Cancer AJCC v8;   Stage III Ovarian Cancer AJCC v8;   Stage III Primary Peritoneal Cancer AJCC v8;...
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
Conditions:   Ann Arbor Stage III Hodgkin Lymphoma;   Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma;   Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma;   Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma;   Ann Arbor Stage IIIA Hodgkin Lymphoma;   Ann Arbor Stage IIIB Hodgkin Lymphoma;   Ann Arbor Stage IV Hodgkin Lymphoma;   Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma;   Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma;...
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Screen to Save: A Colorectal Cancer Educational Intervention
Condition:   Colorectal Cancer Intervention:   Behavioral: Inflatable colon educational module Sponsors:   Dartmouth-Hitchcock Medical Center;   National Cancer Institute (NCI) Active, not recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors
Conditions:   Locally Advanced Malignant Solid Neoplasm;   Metastatic Malignant Solid Neoplasm;   Progressive Disease Interventions:   Drug: Capecitabine;   Drug: Carboplatin;   Biological: Durvalumab;   Drug: Gemcitabine;   Drug: Gemcitabine Hydrochloride;   Drug: Nab-paclitaxel;   Drug: Paclitaxel;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search...
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
NUTRI-HAB - Posttreatment Rehabilitation of Nutrition Impact Symptoms in Head and Neck Cancer Survivors
Condition:   Head and Neck Cancer Intervention:   Other: NUTRI-HAB Sponsors:   Odense University Hospital;   REHPA The Danish Knowledge Centre for rehabilitation and Palliative Care;   University of Southern Denmark;   University College Copenhagen;   Odense Patient Data Explorative Network;   Rigshospitalet, Denmark Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Tue Apr 09, 2019 18:00
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
Conditions:   Actinic Keratoses;   Aging;   Non-Melanoma Skin Cancer Intervention:   Device: Fractionated Laser Resurfacing Sponsor:   Jeffrey B. Travers, MD, PhD Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Non-Squamous NSCLC Patients Previously Treated With Platinum-Based Chemotherapy in Combination With a Checkpoint Inhibitor
Condition:   Non-Squamous Non-Small Cell Lung Cancer Interventions:   Biological: Nivolumab;   Drug: Sitravatinib;   Drug: Docetaxel Sponsors:   Mirati Therapeutics Inc.;   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer
Condition:   Carcinoma, Squamous Cell Interventions:   Drug: A317;   Drug: VTX-2337 Sponsor:   Celgene Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy
Condition:   Nasopharyngeal Carcinoma Intervention:   Drug: Anlotinib Sponsor:   Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Carcinoma Interventions:   Biological: DCVAC/OvCa;   Biological: DCVAC/OvCa placebo Sponsor:   Sotio a.s. Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous NSCLC
Condition:   Non-Squamous Non-Small Cell Lung Cancer Interventions:   Biological: Nivolumab;   Drug: Sitravatinib;   Drug: Docetaxel Sponsors:   Mirati Therapeutics Inc.;   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Conditions:   Non Small Cell Lung Cancer;   Medullary Thyroid Cancer;   Colon Cancer;   Breast Cancer;   Pancreatic Cancer;   Papillary Thyroid Cancer;   Other Solid Tumors With Evidence of Activating RET Alteration Intervention:   Drug: LOXO-292 Sponsors:   Loxo Oncology, Inc.;   Eli Lilly and Company Available (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer
Condition:   Advanced or Metastatic CRC Intervention:   Drug: utidelone injection Sponsors:   Beijing Biostar Technologies, Ltd;   Chengdu Biostar Pharmaceuticals, Ltd Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
Community Colorectal Cancer Awareness, Research, Education & Screening (C-CARES)
Condition:   Colorectal Cancer Interventions:   Behavioral: Community Colorectal Cancer Awareness, Research, Education& Screening (C-CARES) Materials;   Behavioral: Contact Message;   Behavioral: Personalized One on One Education;   Diagnostic Test: Fecal Immunochemical Test (FIT) Sponsor:   H. Lee Moffitt Cancer Center and Research Institute Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social...
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.
Conditions:   Early-stage Breast Cancer;   Hormone Receptor Positive Tumor Interventions:   Drug: Letrozole;   Drug: Letrozole and Prometrium;   Drug: Tamoxifen and Prometrium Sponsor:   St. Vincent's Hospital-Manhattan Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
High Schools- High on Life: an Intervention to Reduce Excessive Drinking in Danish High Schools
Condition:   Alcohol Drinking Intervention:   Behavioral: High schools High on Life Sponsors:   University of Southern Denmark;   Danish Cancer Society Enrolling by invitation (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies
Condition:   Solid Tumor Intervention:   Drug: HS-201 Sponsor:   Herbert Lyerly Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC
Condition:   Advanced Hepatocellular Carcinoma Interventions:   Procedure: TACE;   Drug: Lenvatinib Sponsor:   Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Endostar;   Drug: Chemotherapy Sponsor:   Zhejiang Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Mon Apr 08, 2019 18:00
Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer
Conditions:   Breast Cancer;   Breast Neoplasms;   Hormone Receptor Positive Tumor Intervention:   Diagnostic Test: Multi-parameter tests Sponsors:   Oslo University Hospital;   KLINBEFORSK;   Norwegian Cancer Society Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis
Condition:   Nasopharyngeal Carcinoma Intervention:   Drug: Tegafur-Gimeracil-Oteracil Sponsor:   Zhejiang Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
A Study of Combination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal Cancer
Condition:   Colorectal Cancer Stage III Intervention:   Biological: anti-PD-1 antibody-activated TILs Sponsor:   Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Study to Develop a Prediction Model to Understand the Effect of Low-dose Aspirin on Cancer That Develops in the Colon and/or the Rectum, Diseases That Affects the Heart or Blood Vessels and Safety Outcomes in European Countries. The Study is Also Called PEACOS Model EU
Conditions:   Colorectal Cancer;   Cardiovascular Disease;   Bleeding Intervention:   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465) Sponsor:   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC
Condition:   EGFR-mutant Non-Small Cell Lung Cancer Interventions:   Drug: famitinib po;   Drug: HS-10296 po Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Jaw Reconstruction With Printed Titanium and Free Tissue Transfer
Conditions:   Neoplasm, Oral;   Osteoradionecrosis of Jaw;   Mandibular Diseases;   Jaw Cancer;   Jaw Diseases;   Surgery Intervention:   Procedure: Mandibular reconstruction with free tissue transfer. Sponsor:   University of South Wales Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies
Conditions:   Peripheral T-cell Lymphoma-not Otherwise Specified;   Mycosis Fungoides;   Sezary Syndrome;   ALK-negative Anaplastic Large Cell Lymphoma Interventions:   Drug: rhIL-15;   Biological: Avelumab Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC
Condition:   Breast Cancer Interventions:   Drug: Ribociclib;   Other: Mono-chemotherapy;   Other: Endocrine-Therapy Sponsors:   Swiss Group for Clinical Cancer Research;   The Belgian Society of Medical Oncology Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Exercise Therapy in Radiation Therapy
Condition:   Metastatic Cancer Intervention:   Behavioral: Exercise Therapy Sponsor:   Milton S. Hershey Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Psychological Distress Experience
Conditions:   Psychological Distress;   Cancer Intervention:   Other: Questionnaire Sponsor:   Institut du Cancer de Montpellier - Val d'Aurelle Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation
Conditions:   Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndromes;   Non-hodgkin Lymphoma;   Hodgkin Lymphoma;   Acquired Aplastic Anemia;   Sickle Cell Disease Intervention:   Other: Donor Search Prognosis Score Sponsors:   Center for International Blood and Marrow Transplant Research;   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   Blood and Marrow Transplant Clinical Trials Network;   National Marrow Donor Program;   Medical College of Wisconsin...
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Condition:   Medulloblastoma, Childhood Intervention:   Drug: CX 4945 Sponsors:   Pediatric Brain Tumor Consortium;   St. Jude Children's Research Hospital;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)
Condition:   Small Cell Lung Cancer Intervention:   Drug: CM082 plus JS001 Sponsor:   AnewPharma Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
Condition:   Renal Cell Carcinoma Metastatic Interventions:   Drug: Abemaciclib;   Drug: Sunitinib Sponsors:   Milton S. Hershey Medical Center;   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Focus on Values to Stimulate Shared Decisions
Condition:   Thyroid Cancer Interventions:   Other: Decision aid and SDM booster;   Other: Deliberation training Sponsors:   Radboud University;   Dutch Cancer Society Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Massive Implants the Next Generation
Conditions:   Bone Cancer;   Bone Diseases Intervention:   Device: custom made device Sponsors:   Iva Hauptmannova;   Adler Ortho Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Parental Support Intervention in the Oncological Context
Conditions:   Parent-Child Relations;   Parenting;   Communication Programs Intervention:   Behavioral: Parental guidance Sponsors:   Aurore Liénard;   Centre de Psycho-Oncologie (CPO);   Erasme University Hospital;   Jules Bordet Institute;   Université Libre de Bruxelles Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Local Therapy for Oligorecurrent and Oligoprogressive Esophageal Squamous Cell Carcinoma
Condition:   Oligorecurrent and Oligoprogressive Esophageal Squamous Cell Carcinoma Interventions:   Other: Radiation, Surgery or Radiofrequency ablation;   Drug: Chemotherapy Sponsor:   Fudan University Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Application of Watson for Oncology in Hepatocellular Carcinoma Surgery
Condition:   Liver Resection Intervention:   Other: Watson on oncology surgery decision evaluation Sponsor:   Zhujiang Hospital Active, not recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Sophie Pilot Implementation and Assessment
Conditions:   Depression Chronic;   Advanced Cancer;   Anxiety Interventions:   Behavioral: Sophie CBT System;   Behavioral: iHope CBT Sponsor:   Boston Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia
Condition:   Hyperglycemia Intervention:   Drug: Insulin Sponsor:   H. Lee Moffitt Cancer Center and Research Institute Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient Services
Conditions:   Malignant Solid Tumor;   Pain Interventions:   Procedure: Acupuncture;   Behavioral: Pain Counseling Sponsors:   University of California, San Francisco;   Patient-Centered Outcomes Research Institute Recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00
CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions:   Blasts 5 Percent or More of Bone Marrow Nucleated Cells;   Recurrent Acute Myeloid Leukemia Interventions:   Drug: Gemtuzumab Ozogamicin;   Drug: Liposome-encapsulated Daunorubicin-Cytarabine Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
MedWorm Cancer & Oncology Clinical Trials
Fri Apr 05, 2019 18:00

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου